| Full Name | Jenny M Komac |
|---|---|
| Gender | Female |
| Speciality | Chiropractic |
| Experience | 25 Years |
| Location | 110 Dewey Ave, Eureka, Montana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356422398 | NPI | - | NPPES |
| 0164339 | Medicaid | MT | |
| 0164346 | Medicaid | MT | |
| 42131 | Other | MT | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 919 (Montana) | Primary |
| 111NR0200X | Chiropractor - Radiology | 919 (Montana) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eureka Family Chiropractic P.c. | 3274675020 | 2 |
News Archive
Synageva BioPharma Corp., a biopharmaceutical company developing therapeutic products for rare disorders, announced today the submission to the Comisión Federal para la Protección contra Riesgos Sanitarios in Mexico for Kanuma as a treatment for patients with lysosomal acid lipase deficiency (LAL Deficiency), a rare genetic disease with significant morbidity and early mortality.
Researchers have confirmed that transplanting autologous muscle-derived cells (AMDC) into the bladder is safe at a wide range of doses and significantly improves symptoms and quality of life in patients with stress urinary incontinence.
According to the latest research, a drug derived from plant extracts could wipe out tumors in a single treatment with minimal side effects. Scientists have turned a chemical found in crocuses into a ‘smart bomb' that targets cancerous tumors. The advantage is that healthy tissue is unharmed, reducing the odds of debilitating side effects. And unlike other side effect-free drugs, it is able to kill off more than one type of the disease, including breast, prostate, lung and bowel cancer. Potentially, all solid tumours could be vulnerable to drugs developed this way, meaning it could be used against all but blood cancers.
India Business Council supported ‘Coalition for Healthy India' released the findings of its report on "The Value of Incremental Pharmaceutical Innovation: Benefits for Indian Patients and Indian Business". The report highlights and substantiates the impact of restrictive policies in India, with respect to medical and pharmaceutical innovation.
› Verified 4 days ago
| Provider Name | Eureka Family Chiropractic P.c. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1811183916 PECOS PAC ID: 3274675020 Enrollment ID: O20100118000068 |
News Archive
Synageva BioPharma Corp., a biopharmaceutical company developing therapeutic products for rare disorders, announced today the submission to the Comisión Federal para la Protección contra Riesgos Sanitarios in Mexico for Kanuma as a treatment for patients with lysosomal acid lipase deficiency (LAL Deficiency), a rare genetic disease with significant morbidity and early mortality.
Researchers have confirmed that transplanting autologous muscle-derived cells (AMDC) into the bladder is safe at a wide range of doses and significantly improves symptoms and quality of life in patients with stress urinary incontinence.
According to the latest research, a drug derived from plant extracts could wipe out tumors in a single treatment with minimal side effects. Scientists have turned a chemical found in crocuses into a ‘smart bomb' that targets cancerous tumors. The advantage is that healthy tissue is unharmed, reducing the odds of debilitating side effects. And unlike other side effect-free drugs, it is able to kill off more than one type of the disease, including breast, prostate, lung and bowel cancer. Potentially, all solid tumours could be vulnerable to drugs developed this way, meaning it could be used against all but blood cancers.
India Business Council supported ‘Coalition for Healthy India' released the findings of its report on "The Value of Incremental Pharmaceutical Innovation: Benefits for Indian Patients and Indian Business". The report highlights and substantiates the impact of restrictive policies in India, with respect to medical and pharmaceutical innovation.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jenny M Komac, DC Po Box 1557, Eureka, MT 59917-1557 Ph: (406) 297-2999 | Jenny M Komac, DC 110 Dewey Ave, Eureka, MT 59917 Ph: (406) 297-2999 |
News Archive
Synageva BioPharma Corp., a biopharmaceutical company developing therapeutic products for rare disorders, announced today the submission to the Comisión Federal para la Protección contra Riesgos Sanitarios in Mexico for Kanuma as a treatment for patients with lysosomal acid lipase deficiency (LAL Deficiency), a rare genetic disease with significant morbidity and early mortality.
Researchers have confirmed that transplanting autologous muscle-derived cells (AMDC) into the bladder is safe at a wide range of doses and significantly improves symptoms and quality of life in patients with stress urinary incontinence.
According to the latest research, a drug derived from plant extracts could wipe out tumors in a single treatment with minimal side effects. Scientists have turned a chemical found in crocuses into a ‘smart bomb' that targets cancerous tumors. The advantage is that healthy tissue is unharmed, reducing the odds of debilitating side effects. And unlike other side effect-free drugs, it is able to kill off more than one type of the disease, including breast, prostate, lung and bowel cancer. Potentially, all solid tumours could be vulnerable to drugs developed this way, meaning it could be used against all but blood cancers.
India Business Council supported ‘Coalition for Healthy India' released the findings of its report on "The Value of Incremental Pharmaceutical Innovation: Benefits for Indian Patients and Indian Business". The report highlights and substantiates the impact of restrictive policies in India, with respect to medical and pharmaceutical innovation.
› Verified 4 days ago
Dr. Jack D West, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 198 14 St E, Eureka, MT 59917 Phone: 406-297-2811 | |
Dr. Alice Bain Elrod, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 403 Dewey Ave., Elrod Chiropractic, Eureka, MT 59917 Phone: 406-297-3422 | |
Dr. Jenna Beth Steiner, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 110 Dewey Ave, Eureka, MT 59917 Phone: 406-297-2999 | |
Eureka Family Chiropractic P.c. Chiropractor Medicare: Medicare Enrolled Practice Location: 110 Dewey Ave, Eureka, MT 59917 Phone: 406-297-2999 Fax: 406-297-7999 |